GeneKor’ s Scientific Team has over 15 years of experience in cancer genetics and has performed thousands of hereditary cancer tests.
HerediGENE is designed in order to achieve maximum sensitivity and specificity. All findings are classified using the most reliable and updated databases and in silico analysis algorithms. Advanced Next Generation Sequencing Technology, also known as NGS, is used to fully analyze a panel of genes that are related to hereditary cancer syndromes. Analysis of Large Genomic Rearrangements is also included in HerediGENE, providing comprehensive and reliable information to patients and physicians.
The test results obtained by HerediGENE are clinically actionable. The results provide the physician with specific medical management suggestions for the individual patient, based on the most up-to-date international society guidelines.